105 related articles for article (PubMed ID: 10766300)
1. Pyrimido[4,5,6-kl]acridines. Synthesis, in vitro cytotoxicity and structure-activity relationships.
Antonini I; Polucci P; Martelli S
Anticancer Drug Des; 1999 Oct; 14(5):451-9. PubMed ID: 10766300
[TBL] [Abstract][Full Text] [Related]
2. Rational design, synthesis, and biological evaluation of bis(pyrimido[5,6,1-de]acridines) and bis(pyrazolo[3,4,5-kl]acridine-5-carboxamides) as new anticancer agents.
Antonini I; Polucci P; Magnano A; Sparapani S; Martelli S
J Med Chem; 2004 Oct; 47(21):5244-50. PubMed ID: 15456268
[TBL] [Abstract][Full Text] [Related]
3. Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.
Antonini I; Polucci P; Cola D; Bontemps-Gracz M; Pescalli N; Menta E; Martelli S
Anticancer Drug Des; 1996 Jun; 11(4):339-49. PubMed ID: 8679056
[TBL] [Abstract][Full Text] [Related]
4. Pyrimido[4,5-c]quinolin-1(2H)-ones as a novel class of antimitotic agents: Synthesis and in vitro cytotoxic activity.
Metwally K; Pratsinis H; Kletsas D
Eur J Med Chem; 2007 Mar; 42(3):344-50. PubMed ID: 17141923
[TBL] [Abstract][Full Text] [Related]
5. 2,3-Dihydro-1H,7H-pyrimido[5,6,1-de]acridine-1,3,7-trione derivatives, a class of cytotoxic agents active on multidrug-resistant cell lines: synthesis, biological evaluation, and structure-activity relationships.
Antonini I; Polucci P; Kelland LR; Menta E; Pescalli N; Martelli S
J Med Chem; 1999 Jul; 42(14):2535-41. PubMed ID: 10411474
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents.
Rostom SA; Ashour HM; Abd El Razik HA
Arch Pharm (Weinheim); 2009 May; 342(5):299-310. PubMed ID: 19415663
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 2,8-disubstituted imidazo[1,5-a]pyrimidines with potent antitumor activity.
Matsumoto H; Ikeda K; Nagata N; Takayanagi H; Mizuno Y; Tanaka M; Sasaki T
J Med Chem; 1999 May; 42(9):1661-6. PubMed ID: 10229634
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
Gangjee A; Adair OO; Queener SF
J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2,4,6-functionalized derivatives of pyrido[2,3-d]pyrimidines as cytotoxic agents and apoptosis inducers.
Sanmartín C; Domínguez MV; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
Arch Pharm (Weinheim); 2008 Jan; 341(1):28-41. PubMed ID: 18161903
[TBL] [Abstract][Full Text] [Related]
12. 2,4-Diamino-9H-pyrimido[4,5-b]indol-5-ols: synthesis, in vitro cytotoxic activity, and QSAR investigations.
Dotzauer B; Grünert R; Bednarski PJ; Lanig H; Landwehr J; Troschütz R
Bioorg Med Chem; 2006 Nov; 14(21):7282-92. PubMed ID: 16843672
[TBL] [Abstract][Full Text] [Related]
13. DNA-binding antitumor agents: from pyrimido[5,6,1-de]acridines to other intriguing classes of acridine derivatives.
Antonini I
Curr Med Chem; 2002 Sep; 9(18):1701-16. PubMed ID: 12171552
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in-vitro cytotoxicity, and a preliminary structure-activity relationship investigation of pyrimido[4,5-c]quinoline-1(2H)-ones.
Metwally K; Khalil A; Pratsinis H; Kletsas D
Arch Pharm (Weinheim); 2010 Aug; 343(8):465-72. PubMed ID: 20803623
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new pyrrolo[2,3-d]pyrimidine derivatives and evaluation of their activities against human colon cancer cell lines.
Tangeda SJ; Garlapati A
Eur J Med Chem; 2010 Apr; 45(4):1453-8. PubMed ID: 20163895
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
Xie F; Zhao H; Zhao L; Lou L; Hu Y
Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems.
Fahmy HT; Rostom SA; Bekhit AA
Arch Pharm (Weinheim); 2002 May; 335(5):213-22. PubMed ID: 12210778
[TBL] [Abstract][Full Text] [Related]
20. Novel C-6 fluorinated acyclic side chain pyrimidine derivatives: synthesis, (1)H and (13)C NMR conformational studies, and antiviral and cytostatic evaluations.
Prekupec S; Makuc D; Plavec J; Suman L; Kralj M; Pavelić K; Balzarini J; Clercq ED; Mintas M; Raić-Malić S
J Med Chem; 2007 Jun; 50(13):3037-45. PubMed ID: 17539622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
